Calif. stem cell institute appoints president

After a linkurl:contentious;http://www.the-scientist.com/news/home/53480/ search, the California Institute of Regenerative Medicine on Friday named Australian stem cell research Alan Trounson as the new president of the institute. Trounson, director of the immunology and stem cell laboratories at Monash University, is a long-time expert in IVF and stem cell research and founder of the Australian Stem Cell Center. He has also started a handful of companies to commercialize stem cell research (a

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
After a linkurl:contentious;http://www.the-scientist.com/news/home/53480/ search, the California Institute of Regenerative Medicine on Friday named Australian stem cell research Alan Trounson as the new president of the institute. Trounson, director of the immunology and stem cell laboratories at Monash University, is a long-time expert in IVF and stem cell research and founder of the Australian Stem Cell Center. He has also started a handful of companies to commercialize stem cell research (and has said he will divest from those in which he still holds interests). "It doesn't get any bigger than this," he said of his appointment in an linkurl:interview;http://www.theage.com.au/news/national/stem-cell-pioneer-joins-science-exodus/2007/09/15/1189277050409.html with Australia's daily newspaper, The Age. He is expected to take up the post later this year. The appointment comes as the institute begins to crank into high gear: at the end of this month, California linkurl:will sell;http://www.the-scientist.com/blog/display/53570/ $250 million in bonds, releasing the first chunk of the institute's $3 billion in funding.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies